Browse medicines, page 12 of 49

Use listed on the medicine record

Insomnia characterized by difficulties with sleep onset and/or sleep maintenance

Use listed on the medicine record

Patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease

Use listed on the medicine record

Non-24

Use listed on the medicine record

Hypertension, to lower blood pressure

Use listed on the medicine record

The treatment of adult patients

Use listed on the medicine record

shake well before use, take an appropriate amount of the product and apply it evenly to the facial skin. Gently massage until absorbed.

Use listed on the medicine record

Symptomatic or progressive medullary thyroid cancer

Use listed on the medicine record

Overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency

Use listed on the medicine record

Vigabatrin tablets are indicated for the treatment of: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; Vigabatrin tablets are not indicated as a first line agent ( 1.1 ) Infantile Spasms - monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin tablets are indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with…

Use listed on the medicine record

Invasive aspergillosis

Use listed on the medicine record

Insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep

Use listed on the medicine record

% Acetic Acid Irrigation, USP, is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. It also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations.

Use listed on the medicine record

YUFLYMA is a tumor necrosis factor (TNF) blocker indicated for: Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active r heumatoid arthritis . ( 1.1 ) Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.

Use listed on the medicine record

ABRILADA is a tumor necrosis factor (TNF) blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis . ( 1.1 ) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.

Use listed on the medicine record

Adalimumab-fkjp is a tumor necrosis factor (TNF) blocker indicated for: Rheumatoid Arthritis (RA) ( 1.1 ): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. J uvenile Idiopathic Arthritis (JIA) ( 1.2 ) : reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.

Use listed on the medicine record

Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application

Use listed on the medicine record

reduces underarm wetness

Use listed on the medicine record

ELAlMEl Bee Venom Cream is specially formulated tosupport joint comfort, promote healthy circulation, andenhance mobility. Made with a blend of powerful natura!ingredients, this cream helps soothe discomfort andsupports your active lifestyle.

Use listed on the medicine record

Hypertension, to lower blood pressure

Use listed on the medicine record

Hypertension, to lower blood pressure

Use listed on the medicine record

Mildly to moderately active ulcerative colitis

Use listed on the medicine record

For the removal of common warts and plantar warts.

Use listed on the medicine record

INDICATIONS: May temporarily relieve symptoms associated with sensitivities to phenolic compounds such as rash, fatigue, and lack of concentration.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

Do not apply on other parts of the body Avoid contact with the eyes. In case of accidental contact, rinseeyes with large amounts of cool tap water.Some people have experienced changes in hair color and/or textureIt takes time to regrow hair. Results may occur at 2 months withtwice a day usage. For some men, you may need to use thisproduct for at least 4 months before you see results. The amount of hair regrowth is different for each person. Thisproduct will not work for all people.

Use listed on the medicine record

AnubisMed 50+ Protection Fluid Indications and Usage

Use listed on the medicine record

Capecitabine tablets are a nucleoside metabolic inhibitor indicated for: Colorectal Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen. ( 1.1 ) perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. ( 1.1 ) treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen.

Use listed on the medicine record

Carbidopa tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. Carbidopa tablets are for use with carbidopa-levodopa in patients for whom the dosage of carbidopa-levodopa provides less than adequate daily dosage (usually 70 mg daily) of carbidopa.

Use listed on the medicine record

Postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management

Use listed on the medicine record

For temporary relief of occasional constipation. This product generally produces bowel movement in 6 to 12 hours.

Use listed on the medicine record

Cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, staphylococci, and Streptococcus pyogenes Note: β-lactamase-negative, ampicillin-resistant (BLNAR) strains of Haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some BLNAR strains.

Use listed on the medicine record

The following infections due to susceptible bacteria

Use listed on the medicine record

The loss of ambulation

Use listed on the medicine record

Metastatic colorectal cancer (CRC) with a BRAF V600E mutation, as detected by an FDA-approved test, after prior therapy

Use listed on the medicine record

Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure.

Use listed on the medicine record

Choline C 11 Injection is indicated for positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging (MRI). In these patients, 11 C-choline PET imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. Suspected prostate recurrence is based upon elevated blood prostate specific antigen (PSA) levels following initial therapy. In clinical studies, images were produced with PET/CT coregistration.

Use listed on the medicine record

It repairs, tightens, and combats signs of premature aging, while restoring skin’s natural density and firmness. Twice daily, morning & evening. For the best results, persist in using it

Use listed on the medicine record

Relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease

Use listed on the medicine record

Panic disorder, with or without agoraphobia, as defined in DSM-V

Use listed on the medicine record

adults and children 12 years of age and older: Clean and dry affected area, pop apartand partiallypeel back protective film and apply exposed patch to site of pain, Carefullyremove remaining filmwhile pressing the patch to skin and leave in place for up to 8hours. Use on affected area not morethan 3 to 4 times daily.children under 12 years of age: consult a physicianwash hands after use with cool water

Use listed on the medicine record

The treatment of adult patients with multiple myeloma

Use listed on the medicine record

Anemia due

Use listed on the medicine record

Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase

Use listed on the medicine record

Duchenne muscular dystrophy

Use listed on the medicine record

Maintenance of anesthesia

Use listed on the medicine record

Pregnancy

Use listed on the medicine record

Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )]